The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction

被引:2
|
作者
Lo, Chi-In [1 ,2 ,3 ]
Lai, Yau-Huei [1 ,2 ,3 ]
Chang, Sheng-Nan [4 ]
Kuo, Jen-Yuan [1 ,2 ,3 ]
Hsieh, Ya-Ching [5 ]
Bulwer, Bernard E. [6 ,7 ]
Hung, Chung-Lieh [1 ,8 ,10 ]
Yeh, Hung-I [1 ,2 ,3 ,9 ]
机构
[1] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, 92 Chung Shan North Rd,2nd Sect, Taipei 10449, Taiwan
[2] Mackay Med Coll, Dept Med, Taipei, Taiwan
[3] Mackay Med Nursing & Management Coll, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Yun Lin Branch, Touliu, Yunlin, Taiwan
[5] Peking Univ, Dept Anesthesiol, Hosp 1, Beijing, Peoples R China
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[8] Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei, Taiwan
[9] Mackay Med Coll, Dept Med, New Taipei, Taiwan
[10] Kainan Univ, Dept Hlth Ind Management, Taoyuan, Taiwan
关键词
Co-morbidity; heart failure; myocardial deformation; strain; ventricular geometries; MYOCARDIAL DEFORMATION; COMORBIDITIES; POPULATION; PREVALENCE; PREDICTORS; PROGNOSIS; MORTALITY; TRENDS; STRAIN; IMPACT;
D O I
10.1080/10641963.2016.1273947
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The associations among chronic health conditions, ventricular geometric alterations or cardiac contractile mechanics in different phenotypes heart failure (HF) remain largely unexplored. Methods: We studied 438 consecutive hospitalized patients (mean age: 64.9 16.6 years, 52.5% female) with or without clinical evidence of HF. We examined the associations among clinical co-morbidities, LV geometries and systolic mechanics in terms of global myocardial strains. Results: Increasing clinical co-morbidities was associated with greater LV mass, worse longitudinal deformations and higher proportion of admission with HF diagnosis, which was more pronounced in HFpEF (from 6.4% to 40.7%, X-2 < 0.001). The independent association between co-morbidity burden and longitudinal functional decay remained unchanged after adjusting for age and sex for all admissions and in HFpEF (Coef: 0.82 & 0.71, SE: 0.13 & 0.21, both p0.001). By using co-morbidity scores, the area under receiver operating characteristic curves (AUROC) in identifying HFpEF was 0.71 (95% CI: 0.65 to 0.77), 0.64 (95% CI: 0.58 to 0.71) for HFrEF and 0.72 for both (95% CI: 0.67 to 0.77). Co-morbidity burden superimposed on LV mass index and LV filling pressure (E/E') further expanded the AUROC significantly in diagnosing both types HF (c-statistics from 0.73 to 0.81, p for AUROC: 0.0012). Conclusion: Chronic health conditions in the admission population were associated with unfavorable cardiac remodeling, impair cardiac contractile mechanics and further added significantly incremental value in HF diagnosis. Our data suggested the potentiality for better cardiac function by controlling baseline co-morbidities in hospitalized HF patients, especially HFpEF.Abbreviations:CAD: coronary artery disease; CKD: chronic kidney disease; DT: deceleration time; eGFR: Estimated glomerular filtration rate; HF: heart failure; IVRT: iso-volumic relaxation time; LV: left ventricular; LVEF: left ventricular ejection fraction; RWT: relative wall thickness; TDI: Tissue Doppler imaging
引用
收藏
页码:473 / 480
页数:8
相关论文
共 50 条
  • [21] Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
    Ahn, Min-Soo
    Yoo, Byung-Su
    Son, Jung-Woo
    Park, Young Jun
    Lee, Hae-Young
    Jeon, Eun-Seok
    Kang, Seok-Min
    Choi, Dong-Ju
    Kim, Kye Hun
    Cho, Myeong-Chan
    Kim, Seong Yoon
    Kang, Dae Ryong
    Go, Tae-Hwa
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (40) : 1 - 13
  • [22] Comparison of morbidity in women versus men with heart failure and preserved ejection fraction
    Deswal, A
    Bozkurt, B
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (08): : 1228 - 1231
  • [23] Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction
    Ziaeian, Boback
    Heidenreich, Paul A.
    Xu, Haolin
    DeVore, Adam D.
    Matsouaka, Roland A.
    Hernandez, Adrian F.
    Bhatt, Deepak L.
    Yancy, Clyde W.
    Fonarow, Gregg C.
    [J]. JACC-HEART FAILURE, 2017, 5 (07) : 483 - 493
  • [24] CHARACTERIZATION AND IMPACT OF COMORBIDITY AMONG GENDER AND RACIAL SUBGROUPS HOSPITALIZED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Goyal, Parag
    Paul, Tracy
    Almarzooq, Zaid I.
    Swaminathan, Rajesh
    Feldman, Dmitriy
    Peterson, Janey
    Karas, Maria
    Sobol, Irina
    Horn, Evelyn
    Kim, Luke
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1463 - 1463
  • [25] Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction
    Reddy, Yogesh N., V
    Obokata, Masaru
    Jones, Aaron D.
    Lewis, Gregory D.
    Shah, Sanjiv J.
    Abouezzedine, Omar F.
    Fudim, Marat
    Alhanti, Brooke
    Stevenson, Lynne W.
    Redfield, Margaret M.
    Borlaug, Barry A.
    [J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (11) : 919 - 928
  • [26] Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    Butler, Javed
    Zannad, Faiez
    Ferreira, Joao Pedro
    Ofstad, Anne Pernille
    Iwata, Tomoko
    Brueckmann, Martina
    Pocock, Stuart J.
    Packer, Milton
    Anker, Stefan D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 970 - 977
  • [27] Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
    Wenzel, Jan-Per
    Kellen, Ramona Bei der
    Magnussen, Christina
    Blankenberg, Stefan
    Schrage, Benedikt
    Schnabel, Renate
    Nikorowitsch, Julius
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (04) : 416 - 427
  • [28] Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
    Jan-Per Wenzel
    Ramona Bei der Kellen
    Christina Magnussen
    Stefan Blankenberg
    Benedikt Schrage
    Renate Schnabel
    Julius Nikorowitsch
    [J]. Clinical Research in Cardiology, 2022, 111 : 416 - 427
  • [29] Cardiac Amyloidosis. Redefining heart failure with preserved ejection fraction
    Gabilondo, Ivan
    Cartasegna, Luis
    Camilletti, Jorge
    Manganiello, Carlos F.
    [J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2020, 49
  • [30] Targeting coagulation in heart failure with preserved ejection fraction and cardiac fibrosis
    Hofmann, Christoph
    Voelkers, Rko
    Katus, Hugo A.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (40) : 3333 - 3335